We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
IBA-Radcal

Download Mobile App




Skin Bioprinting System Helps Heal Extensive Wounds

By HospiMedica International staff writers
Posted on 12 Mar 2019
A mobile skin bioprinter that layers dermal fibroblasts and epidermal keratinocytes directly into a wound can accelerate contraction and re-epithelialization, claims a new study.

Developed at the Wake Forest Institute for Regenerative Medicine (WFIRM; Winston-Salem, NC, USA), the mobile bioprinting system first isolates the major skin cells--dermal fibroblasts and epidermal keratinocytes-- from a small biopsy of uninjured tissue. More...
The cells are then expanded and mixed into a hydrogel and placed into the bioprinter. Using integrated imaging technology the wound is then scanned; the data is used to direct the print heads on which cells to deliver exactly where in the wound, layer by layer.

The process thus replicates and accelerates the formation of normal skin structure and function. The fibroblasts synthesize extracellular matrix (ECM) and collagen, which play a critical role in wound healing, while the keratinocytes reconstruct the epidermis, the outermost layer of the skin. The regenerated tissues show a dermal structure and composition similar to healthy skin, with extensive collagen deposition arranged in large, organized fibers, extensive mature vascular formation, and proliferating keratinocytes. The study was published on February 12, 2019, in Nature Scientific Reports.

“The unique aspect of this technology is the mobility of the system and the ability to provide on-site management of extensive wounds by scanning and measuring them in order to deposit the cells directly where they are needed to create skin,” said lead author Sean Murphy, PhD. “Currently, skin grafts to treat wounds and burns are the ‘gold standard’ technique, but adequate coverage of wounds is often a challenge, particularly when there is limited availability of healthy skin to harvest.”

The early treatment and rapid closure of acute or chronic wounds is essential for normal healing and prevention of hypertrophic scarring; but the use of split thickness autografts is often limited by the availability of a suitable area of healthy donor skin to harvest. Cellular and non-cellular biological skin-equivalents are commonly used as an alternative treatment option for these patients, however these treatments usually involve multiple surgical procedures and are associated with high costs of production and repeated wound treatment.

Related Links:
Wake Forest Institute for Regenerative Medicine


Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Pressure Guidewire
SavvyWire
Surgical Headlight
IsoTorch
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Critical Care

view channel
Image: The 3D-printed microneedle patch boosts live-virus vaccine delivery (Photo courtesy of IIS/University of Tokyo)

3D-Printed Delivery System Enhances Vaccine Delivery Via Microneedle Array Patch

The COVID-19 pandemic underscored the need for efficient, durable, and widely accessible vaccines. Conventional vaccination requires trained personnel and cold-chain logistics, which can slow mass immunization... Read more

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.